DK129468B - Fremgangsmåde til dyrkning af virus. - Google Patents

Fremgangsmåde til dyrkning af virus.

Info

Publication number
DK129468B
DK129468B DK223371AA DK223371A DK129468B DK 129468 B DK129468 B DK 129468B DK 223371A A DK223371A A DK 223371AA DK 223371 A DK223371 A DK 223371A DK 129468 B DK129468 B DK 129468B
Authority
DK
Denmark
Prior art keywords
culturing viruses
viruses
culturing
Prior art date
Application number
DK223371AA
Other languages
Danish (da)
English (en)
Other versions
DK129468C (cg-RX-API-DMAC10.html
Inventor
P Prunet
Original Assignee
Bellon R Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellon R Sa Lab filed Critical Bellon R Sa Lab
Publication of DK129468B publication Critical patent/DK129468B/da
Application granted granted Critical
Publication of DK129468C publication Critical patent/DK129468C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18161—Methods of inactivation or attenuation
    • C12N2760/18164—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK223371AA 1970-05-11 1971-05-10 Fremgangsmåde til dyrkning af virus. DK129468B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707017053A FR2088038B1 (cg-RX-API-DMAC10.html) 1970-05-11 1970-05-11

Publications (2)

Publication Number Publication Date
DK129468B true DK129468B (da) 1974-10-14
DK129468C DK129468C (cg-RX-API-DMAC10.html) 1975-03-03

Family

ID=9055329

Family Applications (1)

Application Number Title Priority Date Filing Date
DK223371AA DK129468B (da) 1970-05-11 1971-05-10 Fremgangsmåde til dyrkning af virus.

Country Status (12)

Country Link
BE (1) BE766442A (cg-RX-API-DMAC10.html)
CH (1) CH532659A (cg-RX-API-DMAC10.html)
CS (1) CS178080B2 (cg-RX-API-DMAC10.html)
DE (1) DE2121237C3 (cg-RX-API-DMAC10.html)
DK (1) DK129468B (cg-RX-API-DMAC10.html)
ES (1) ES390873A1 (cg-RX-API-DMAC10.html)
FR (1) FR2088038B1 (cg-RX-API-DMAC10.html)
GB (1) GB1338043A (cg-RX-API-DMAC10.html)
HU (1) HU165705B (cg-RX-API-DMAC10.html)
NL (1) NL7106379A (cg-RX-API-DMAC10.html)
PL (1) PL88908B1 (cg-RX-API-DMAC10.html)
RO (1) RO62179A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801601A (nl) * 1988-06-23 1990-01-16 Centraal Diergeneeskundig Inst Een "swine-kidney" celcultuur, geschikt voor het kweken van virussen, een daaraan geadapteerde "chinese" stam van het varkenspestvirus, alsmede de hiervan afgeleide vaccins.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299514A (fr) * 1960-11-25 1962-07-27 Bayer Ag Procédé de reproduction du virus de la fièvre aphteuse
DE1174016B (de) * 1962-05-18 1964-07-16 Behringwerke Ag Verfahren zur Herstellung einer Lebend-Vaccine gegen Maul- und Klauenseuche

Also Published As

Publication number Publication date
ES390873A1 (es) 1975-03-16
BE766442A (fr) 1971-09-16
HU165705B (cg-RX-API-DMAC10.html) 1974-10-28
DE2121237A1 (de) 1971-12-02
CH532659A (fr) 1973-01-15
DE2121237C3 (de) 1980-03-06
NL7106379A (cg-RX-API-DMAC10.html) 1971-11-15
RO62179A (cg-RX-API-DMAC10.html) 1977-05-15
CS178080B2 (cg-RX-API-DMAC10.html) 1977-08-31
FR2088038A1 (cg-RX-API-DMAC10.html) 1972-01-07
DK129468C (cg-RX-API-DMAC10.html) 1975-03-03
FR2088038B1 (cg-RX-API-DMAC10.html) 1973-08-10
DE2121237B2 (de) 1979-07-05
GB1338043A (en) 1973-11-21
PL88908B1 (cg-RX-API-DMAC10.html) 1976-10-30

Similar Documents

Publication Publication Date Title
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK136218B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxysteroider af pregnan- eller 19-norpregnanrækken.
DK123307B (da) Fremgangsmåde ved dyrkning af en virus.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK123236B (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydoxy-4,5-dihydrofuran-4-oner.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK121052B (da) Fremgangsmåde til fremstilling af steroid-17α,21-orthocarbonater.
DK132447B (da) Fremgangsmåde til fremstilling af kalvediarrevirusvaccine.
DK129468B (da) Fremgangsmåde til dyrkning af virus.
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
FI49627C (fi) Menetelmä viruksen viljelemiseksi.
DK109407C (da) Fremgangsmåde til dyrkning af overførbar gastroenteritis virus.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK133682B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-5alfa-pregn-1-en-20-oner eller 3alfa-hydroxy-17beta-alkoxykarbonyl-5alfa-androst-1-ener.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK125244B (da) Fremgangsmåde til fremstilling af 9α-fluor-16-methyl-prednisolon eller -prednison eller 21-estere deraf.
DK122824B (da) Fremgangsmåde til afsvækkelse af virus.
DK126186B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9-diener.
DK125790B (da) Fremgangsmåde til fremstilling af L-β-3,4-dihydroxyphenyl-α-alanin.
DK128942B (da) Fremgangsmåde til fremstilling af L-asparaginase.
DK127414B (da) Analogifremgangsmåde til fremstilling af phenylhydrazider.
DK127852B (da) Analogifremgangsmåde til fremstilling af 22-substituerede cardenolidrhamnosider.
DK129836B (da) Analogifremgangsmåde til fremstilling af 21-fluor-3β-hydroxy-pregna-5,16-dien-20-on eller estere deraf.